One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Durability of Mitral Valve Transcatheter Edge-to-Edge Repair: An Expert Overview
Management Approach for Residual and Recurrent Mitral Regurgitation After Transcatheter Edge-to-Edge Repair
Phenotypic Diversity and Outcomes of Transcatheter Mitral Repair for Secondary Mitral Regurgitation: Insights From the COAPT and MITRA-FR Trials
30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve Disease
Transseptal TMVR With the Cephea Valve: A Step in the Right Direction
Long-Term Outcomes in Patients With New-Onset Left Bundle Branch Block Following TAVR
Precision Medicine With Individualized Clinical Surveillance After TAVR
1-Year Real-World Outcomes With the Amulet Occluder From the EMERGE LAA Postapproval Study
Left Atrial Appendage Occlusion: Are Accumulating Data Enough to Change Clinical Practice?
2-Year Outcomes Following Transseptal Mitral Valve Replacement With the HighLife System
Jet-to-Commissure Index Predicts Procedural Results in Transcatheter Mitral Valve Edge-to-Edge Repair for Functional Mitral Regurgitation
Embolic Protection With the Emboliner for Structural Heart Procedures With Extreme Embolic Risk
M-TEER for Mitral Regurgitation: Does RESHAPE-HF2 Break the Tie or Muddy the Waters?
Anticipating Landmark Outcomes Trials in Intermediate-Risk PE: Patient Selection and Implications for 2026 Guidelines
Successful Treatment of Left Ventricular Outflow Obstruction With Mitral Transcatheter Edge-to-Edge Repair Using PASCAL Ace
TAVR in Patients With Prior Iliofemoral Stenting: Not All Stent Platforms Are Equal
Genotype-Guided vs Conventional Oral P2Y�₂ Inhibitors in Acute Coronary Syndrome
REPLY: Genotype-Guided vs Conventional Oral P2Y�₂ Inhibitors in Acute Coronary Syndrome
